DHCNI Diversified Healthcare Trust - 5.625% Senior Notes due 2042
DHCNI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DHCNI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount |
|---|---|
| July 15, 2026 | $0.3520 |
| April 15, 2026 | $0.3520 |
| Jan. 15, 2026 | $0.3520 |
| Oct. 15, 2025 | $0.3520 |
| July 15, 2025 | $0.3520 |
| April 15, 2025 | $0.3520 |
| Jan. 15, 2025 | $0.3520 |
| Oct. 15, 2024 | $0.3520 |
| July 15, 2024 | $0.3520 |
| April 12, 2024 | $0.3520 |
| Jan. 11, 2024 | $0.3520 |
| Oct. 12, 2023 | $0.3520 |
| July 13, 2023 | $0.3520 |
| April 13, 2023 | $0.3520 |
| Jan. 12, 2023 | $0.3520 |
| Oct. 13, 2022 | $0.3520 |
| July 14, 2022 | $0.3520 |
| April 13, 2022 | $0.3520 |
| Jan. 13, 2022 | $0.3520 |
| Oct. 14, 2021 | $0.3520 |
DHCNI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 1 11.1%
- Buy 5 55.6%
- Hold 3 33.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.16 | $-0.15 | -0.01% |
| March 31, 2026 | $-0.18 | $-0.16 | -0.02% |
| Dec. 31, 2025 | $-0.09 | $-0.18 | 0.09% |
| Sept. 30, 2025 | $-0.68 | $-0.22 | -0.46% |
| June 30, 2025 | $-0.38 | $-0.22 | -0.16% |
| March 31, 2025 | $0.05 | $-0.22 | 0.27% |
| Sept. 30, 2024 | $0.02 | $-0.26 | 0.28% |
| Sept. 30, 2023 | $0.03 | $-0.21 | 0.24% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DHCNI | — | — | — | — | — | — |
| HR | $5.96B | -23.9 | -6.9% | -20.8% | -5.0% | — |
| SBRA | $4.77B | 29.6 | 10.2% | 20.1% | 5.6% | — |
| NHI | $3.69B | 25.3 | 12.1% | 37.9% | 9.8% | — |
| MPT | $2.99B | -10.9 | -2.4% | -28.5% | -5.9% | — |
| LTC | $1.67B | 13.6 | 25.3% | 44.9% | 11.6% | — |
| DHC | $1.17B | -4.1 | 2.8% | -18.6% | -16.2% | — |
| UHT | $544M | 30.9 | 0.18% | 17.8% | 10.6% | — |
| XRN | $447M | -37.1 | 6.8% | -4.6% | -1.3% | — |
| CHCT | $467M | 205.2 | 4.7% | 4.2% | 1.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 10
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| Revenue | $255M | $159M | |
| SG&A Expense | $10M | $8M | |
| Operating Expenses | $178M | $96M | |
| Operating Income | $77M | $62M | |
| Interest Expense | $39M | $30M | |
| Pretax Income | $38M | $26M | |
| Income Tax | $146.0K | $43.0K | |
| Shares (Basic) | 237,263,000 | 174,690,000 | |
| Shares (Diluted) | 237,293,000 | · | |
| EBITDA | $147M | $98M |
Balance Sheet 10
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| Cash & Equivalents | $61M | $21M | |
| Intangibles | $629M | $107M | |
| Total Assets | $7.35B | $4.65B | |
| Total Liabilities | $3.85B | $1.98B | |
| Common Stock | $2M | $2M | |
| Retained Earnings | $1.47B | $999M | |
| AOCI | $-1M | $5M | |
| Stockholders' Equity | $3.51B | $2.67B | |
| Liabilities + Equity | $7.35B | $4.65B | |
| Shares Outstanding | 237,471,559 | 176,553,600 |
Cash Flow 1
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| D&A | $70M | $36M |
Profitability 4
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| Operating Margin | 30.3% | 39.3% | |
| Pretax Margin | 15.0% | 16.2% | |
| EBITDA Margin | 57.7% | 61.9% | |
| ROIC | 2.2% | 2.3% |
Liquidity & Solvency 1
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| Interest Coverage | 2.0 | 2.0 |
Efficiency 1
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Valuation (TTM) 5
| Metric | Trend | Q3 2015 | Q3 2012 |
|---|---|---|---|
| Revenue TTM | $961M | $580M | |
| Net Income TTM | · | $135M | |
| Market Cap | $5.83B | $4.36B | |
| P/S | 6.1 | 7.5 | |
| P/B | 1.7 | 1.6 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| FLAT FOOTED LLC, MARC ANDERSEN | June 27, 2023 | — | Initial filing | — | SEC |
| HRPT Properties Trust I.R.S. ID No., Reit Management & Research LLC I.R.S. ID No., Reit Management & Research Trust I.R.S. ID No., Barry M. Portnoy, Adam D. Portnoy ×2 filings | Nov. 8, 2005 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.